Transcriptome analysis of changes associated with dexrazoxane or GDF15 pretreatment to protect against doxorubicin in human embryonic stem cell-derived cardiomyocytes
Clicks: 5
ID: 323396
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
1.2
/100
5 views
4 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #160 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background/Introduction We recently showed in human embryonic stem cell-derived cardiomyocytes (hESC-CMs) that growth differentiation factor 15 (GDF15) attenuated doxorubicin (Dox)-induced toxicity and mitochondrial dysfunction with a similar efficacy to dexrazoxane, an approved cardioprotective agent. Purpose We aim to perform RNA sequencing (RNA-Seq) to reveal gene expression changes associated with GDF15 or dexrazoxane pretreatment preceding Dox exposure in hESC-CMs. Methods hESC-CMs were cultured for 60–120 days, exhibited spontaneous beating, and expressed cardiac troponin protein in >90% cells. Dexrazoxane (Dex, 200µM, 1h) or GDF15 (300ng/ml, 24h) were applied to hESC-CMs as pretreatment before incubation with doxorubicin (Dox, 1.5µM) for 8h. Thereafter, total RNA was isolated, checked for integrity, and sequenced. RNA library was constructed using 1μg total RNA. Illumina NextSeq 500 was used for sequencing and 100bp paired-end reads were generated. Quality trimmed reads were mapped to the human genome (mm10) by Tophat2, and gene expression mapped reads of genes overlapping with gene annotations in Ensemble release 96 were calculated by Cufflinks. DESEQ2 was used for detecting differentially expressed gene (DEG) transcripts at 8h. Three biological replicates were used for each condition. Significant DEGs were defined as log2 fold change >1 or <-1, and p<0.05. Gene set enrichment was done using Gene Ontology analysis with FDR q≤0.05. Experimental groups were comparatively analysed: 1) Dox vs. Control, 2) GDF15 + Dox vs. Dox, and 3) Dexrazoxane + Dox vs. Dox. Select genes were validated by qPCR. Results In Group 1 analysis, Dox significantly upregulated 796 genes and downregulated 1,561 genes relative to Control (Fig A). Genes involved in negative regulation of cell proliferation were upregulated, whereas those related to transcription were suppressed (Fig B). Proapoptotic genes, including TP53 and FAS, were increased by Dox, whereas antiapoptotic genes (MMP11, CXCL7, PIK3R1) and genes related to heart development (HAND2, IRX4, NKX2-5) and cellular response to fatty acid (CREB1) and insulin (IRS1) were decreased, suggesting compromised cardiac metabolism and repair. In Group 2 analysis, GDF15 upregulated 187 and downregulated 24 genes. Significantly increased DEGs were related to SMAD and prosurvival (FZD4, GDF6, TCF7, FZD2, GDF7, WNT4) signalling pathways (Fig C). In Group 3 analysis, 52 and 125 genes were upregulated and downregulated, respectively. Increased DEGs were those associated with proliferation (IL6R, NTRK2), whereas others related to growth suppression and apoptosis (MT2A, MT1E, MT1F) were decreased (Fig D). Prosurvival genes upregulated by GDF15 against Dox were validated by qPCR (Fig E). Conclusion(s) Transcriptome analysis revealed known genes associated with Dox cytotoxicity and Dex-induced cytoprotection, and identified GDF15-upregulated downstream prosurvival genes that warrant future mechanistic studies.
| Reference Key |
openalex_W7172300797
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | E Fung, H Luo, L Huang, J C H Chen, W Zhu, E N Poon |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag097.237
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.